Fred Alger Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-45,987
| Closed | -$185K | – | 551 |
|
|
2022
Q2 | $185K | Buy |
+45,987
| New | +$185K | ﹤0.01% | 429 |
|
|
2021
Q3 | – | Sell |
-67,584
| Closed | -$958K | – | 541 |
|
|
2021
Q2 | $958K | Sell |
67,584
-2,893
| -4% | -$41K | ﹤0.01% | 398 |
|
|
2021
Q1 | $1.16M | Sell |
70,477
-1,036
| -1% | -$17K | ﹤0.01% | 370 |
|
|
2020
Q4 | $1.48M | Sell |
71,513
-59,326
| -45% | -$1.23M | ﹤0.01% | 343 |
|
|
2020
Q3 | $996K | Sell |
130,839
-9,161
| -7% | -$69.7K | ﹤0.01% | 344 |
|
|
2020
Q2 | $1.17M | Buy |
140,000
+105,000
| +300% | +$875K | ﹤0.01% | 337 |
|
|
2020
Q1 | $173K | Buy |
+35,000
| New | +$173K | ﹤0.01% | 399 |
|
|
2015
Q4 | – | Sell |
-35,307
| Closed | -$496K | – | 584 |
|
|
2015
Q3 | $496K | Hold |
35,307
| – | – | ﹤0.01% | 436 |
|
|
2015
Q2 | $743K | Buy |
35,307
+5,650
| +19% | +$119K | ﹤0.01% | 442 |
|
|
2015
Q1 | $1.25M | Buy |
+29,657
| New | +$1.25M | 0.01% | 486 |
|